1. Suwannamajo, R, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C. Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody. Clin Cosmet Investig Dermatol. 2024;17 :301-309. doi: 10.2147/CCID.S443069. PubMed PMID:38314147 PubMed Central PMC10838517.
  2. Foocharoen, T, Onchan, T, Pongkulkiat, P, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C et al.. Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health. Open Access Rheumatol. 2023;15 :213-222. doi: 10.2147/OARRR.S434983. PubMed PMID:37954513 PubMed Central PMC10638938.
  3. Foocharoen, C, Kingkaew, P, Teerawattananon, Y, Mahakkanukrauh, A, Suwannaroj, S, Manasirisuk, W et al.. Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients. Int J Rheum Dis. 2023;26 (10):2037-2046. doi: 10.1111/1756-185X.14868. PubMed PMID:37665078 .
  4. Wongthawa, N, So-Gnern, A, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C. Sleep quality and clinical association with sleep disturbance in systemic sclerosis. BMC Rheumatol. 2023;7 (1):21. doi: 10.1186/s41927-023-00346-7. PubMed PMID:37480089 PubMed Central PMC10360221.
  5. Foocharoen, C, Ngamjarus, C, Pattanittum, P, Suwannaroj, S, Pongkulkiat, P, Onchan, T et al.. Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. Clin Rheumatol. 2023;42 (7):1767-1774. doi: 10.1007/s10067-023-06550-7. PubMed PMID:36894730 PubMed Central PMC9998257.
  6. Wantha, O, Mahakkanukrauh, A, Tuydaung, K, Donsrichan, W, Yingyaun, K, Kaewmeun, S et al.. Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients. Int J Rheum Dis. 2023;26 (4):751-758. doi: 10.1111/1756-185X.14644. PubMed PMID:36872073 .
  7. Sangaroon, A, Foocharoen, C, Theerakulpisut, D, Srichompoo, K, Mahakkanukrauh, A, Suwannaroj, S et al.. Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis. Sci Rep. 2022;12 (1):18198. doi: 10.1038/s41598-022-21914-w. PubMed PMID:36307496 PubMed Central PMC9616808.
  8. Laovirojjanakul, W, Yospaiboon, Y, Anutarapongpan, O, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis. Clin Ophthalmol. 2022;16 :3447-3455. doi: 10.2147/OPTH.S387760. PubMed PMID:36262930 PubMed Central PMC9574561.
  9. Foocharoen, C, Thinkhamrop, W, Chaichaya, N, Mahakkanukrauh, A, Suwannaroj, S, Thinkhamrop, B et al.. Development and validation of machine learning for early mortality in systemic sclerosis. Sci Rep. 2022;12 (1):17178. doi: 10.1038/s41598-022-22161-9. PubMed PMID:36229500 PubMed Central PMC9563044.
  10. Thepwiwatjit, S, Charoensri, S, Sirithanaphol, W, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C et al.. Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis. J Scleroderma Relat Disord. 2022;7 (3):234-242. doi: 10.1177/23971983221112021. PubMed PMID:36211203 PubMed Central PMC9537708.
  11. Sriwong, WT, Srisangwarn, P, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C. Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study. Clin Rheumatol. 2023;42 (1):117-124. doi: 10.1007/s10067-022-06353-2. PubMed PMID:36042067 .
  12. So-Ngern, A, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R, Foocharoen, C. Skin thickness affects the result of tuberculin skin test in systemic sclerosis. BMC Rheumatol. 2022;6 (1):48. doi: 10.1186/s41927-022-00278-8. PubMed PMID:35962447 PubMed Central PMC9375415.
  13. Pongkulkiat, P, Thinkhamrop, B, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C. Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis. BMC Rheumatol. 2022;6 (1):33. doi: 10.1186/s41927-022-00262-2. PubMed PMID:35650637 PubMed Central PMC9161481.
  14. Foocharoen, C, Tonsawan, P, Pongkulkiat, P, Anutrakulchai, S, Mahakkanukrauh, A, Suwannaroj, S et al.. Management review of scleroderma renal crisis: An update with practical pointers. Mod Rheumatol. 2023;33 (1):12-20. doi: 10.1093/mr/roac028. PubMed PMID:35349704 .
  15. Foocharoen, C, Mahakkanukrauh, A, Maleewong, P, Maleewong, W, Jumnainsong, A, Pongkulkiat, P et al.. Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients. Am J Med Sci. 2022;363 (6):519-525. doi: 10.1016/j.amjms.2021.10.031. PubMed PMID:35296408 .
  16. Rompsaithong, U, Sirithanaphol, W, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C. Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis. Rheumatology (Oxford). 2022;61 (10):4016-4023. doi: 10.1093/rheumatology/keac052. PubMed PMID:35108366 .
  17. Paolee, Y, Foocharoen, C, Charoensri, S, Mayxay, M, Mahakkanukrauh, A, Suwannaroj, S et al.. The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients. Sci Rep. 2021;11 (1):14902. doi: 10.1038/s41598-021-94371-6. PubMed PMID:34290330 PubMed Central PMC8295267.
  18. Pussadhamma, B, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R, Foocharoen, C. Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study). Am J Med Sci. 2021;362 (6):570-577. doi: 10.1016/j.amjms.2021.05.027. PubMed PMID:34087232 .
  19. Chuealee, W, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Pongchaiyakul, C, Nanagara, R et al.. Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis. Sci Rep. 2021;11 (1):9424. doi: 10.1038/s41598-021-88792-6. PubMed PMID:33941800 PubMed Central PMC8093198.
  20. Foocharoen, C, Peansukwech, U, Pongkulkiat, P, Mahakkanukrauh, A, Suwannaroj, S. Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database. Sci Rep. 2021;11 (1):7983. doi: 10.1038/s41598-021-87114-0. PubMed PMID:33846466 PubMed Central PMC8042026.
  21. Pussadhamma, B, Tipparot, T, Chaosuwannakit, N, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study. Int J Rheumatol. 2020;2020 :8884442. doi: 10.1155/2020/8884442. PubMed PMID:33414828 PubMed Central PMC7769651.
  22. Jutiviboonsuk, A, Salang, L, Eamudomkarn, N, Mahakkanukrauh, A, Suwannaroj, S, Foocharoen, C et al.. Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. Clin Rheumatol. 2021;40 (6):2267-2275. doi: 10.1007/s10067-020-05522-5. PubMed PMID:33244723 .
  23. Krikeerati, T, Pussadhamma, B, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R, Foocharoen, C et al.. Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. Mod Rheumatol. 2021;31 (3):649-656. doi: 10.1080/14397595.2020.1823067. PubMed PMID:32924684 .
  24. Arunsurat, I, Mahakkanukrauh, A, Foocharoen, C, Suwannaroj, S, Nanagara, R, scleroderma research group et al.. Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease. Clin Rheumatol. 2021;40 (1):205-211. doi: 10.1007/s10067-020-05217-x. PubMed PMID:32519048 .
  25. Foocharoen, C, Peansukwech, U, Mahakkanukrauh, A, Suwannaroj, S, Pongkulkiat, P, Khamphiw, P et al.. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. Int J Rheum Dis. 2020;23 (7):945-957. doi: 10.1111/1756-185X.13859. PubMed PMID:32420701 .
  26. Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R, Foocharoen, C. Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis. Arch Med Sci. 2021;17 (6):1696-1705. doi: 10.5114/aoms.2019.85172. PubMed PMID:34900051 PubMed Central PMC8641511.
  27. Foocharoen, C, Chunlertrith, K, Mairiang, P, Mahakkanukrauh, A, Suwannaroj, S, Namvijit, S et al.. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. Sci Rep. 2020;10 (1):769. doi: 10.1038/s41598-020-57636-0. PubMed PMID:31964957 PubMed Central PMC6972652.
  28. Foocharoen, C, Peansukwech, U, Pongkulkiat, P, Mahakkanukrauh, A, Suwannaroj, S. Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database. Mod Rheumatol. 2020;30 (6):1025-1032. doi: 10.1080/14397595.2019.1702238. PubMed PMID:31813338 .
  29. Tipparot, T, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R, Pussadhamma, B et al.. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study. Int J Rheum Dis. 2019;22 (12):2125-2133. doi: 10.1111/1756-185X.13727. PubMed PMID:31659856 .
  30. Apipattarakul, R, Foocharoen, C, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Limpawattana, P et al.. Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. Clin Exp Rheumatol. 2018;36 Suppl 113 (4):76-81. . PubMed PMID:29998834 .
  31. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  32. Foocharoen, C, Watcharenwong, P, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis. 2017;20 (10):1572-1581. doi: 10.1111/1756-185X.13060. PubMed PMID:28296274 .
  33. Daungkum, K, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Thinkhamrop, B, Nanagara, R et al.. Self-assessment of skin tightness severity by scleroderma patients. Int J Rheum Dis. 2016;19 (10):989-995. doi: 10.1111/1756-185X.12879. PubMed PMID:27126197 .
  34. Suebmee, P, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Theerakulpisut, D, Nanagara, R et al.. Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. Am J Med Sci. 2016;352 (2):166-71. doi: 10.1016/j.amjms.2016.04.017. PubMed PMID:27524215 .
  35. Foocharoen, C, Chunlertrith, K, Mairiang, P, Mahakkanukrauh, A, Suwannaroj, S, Namvijit, S et al.. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. Rheumatology (Oxford). 2017;56 (2):214-222. doi: 10.1093/rheumatology/kew216. PubMed PMID:27179107 .
  36. Foocharoen, C, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma. Int J Rheum Dis. 2016;19 (9):913-23. doi: 10.1111/1756-185X.12884. PubMed PMID:27126733 .
  37. Foocharoen, C, Thinkhamrop, B, Mahakkanukrauh, A, Suwannaroj, S, Netwijitpan, S, Sripavatakul, K et al.. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study. J Med Assoc Thai. 2015;98 (11):1082-8. . PubMed PMID:26817178 .
  38. Sumphao-Ngern, P, Foocharoen, C, Boonsawat, W, Mahakkanukrauh, A, Suwannaroj, S, Sae-Oue, U et al.. Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis. Arch Med Sci. 2015;11 (6):1255-60. doi: 10.5114/aoms.2015.56352. PubMed PMID:26788088 PubMed Central PMC4697058.
  39. Foocharoen, C, Pussadhamma, B, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Rheumatology (Oxford). 2015;54 (9):1616-21. doi: 10.1093/rheumatology/kev096. PubMed PMID:25863044 .
  40. Foocharoen, C, Yenrom, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Prevalence and causes of loss to follow-up among patients with systemic sclerosis. J Clin Rheumatol. 2014;20 (8):456. doi: 10.1097/RHU.0000000000000198. PubMed PMID:25417691 .
  41. Foocharoen, C, Suwannachat, P, Netwijitpan, S, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R et al.. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Int J Rheum Dis. 2016;19 (3):312-20. doi: 10.1111/1756-185X.12492. PubMed PMID:25293362 .
  42. Foocharoen, C, Mahakkanukrauh, A, Pussadhamma, B, Netwijitpan, S, Suwannaroj, S, Nanagara, R et al.. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary?. J Clin Rheumatol. 2014;20 (5):268-74. doi: 10.1097/RHU.0000000000000120. PubMed PMID:25036561 .
  43. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. J Med Assoc Thai. 2014;97 (1):28-35. . PubMed PMID:24701726 .
  44. Kitchongcharoenying, P, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. Asian Pac J Allergy Immunol. 2013;31 (4):314-9. doi: 10.12932/AP0305.31.4.2013. PubMed PMID:24383974 .
  45. Mahakkanukrauh, A, Thavornpitak, Y, Foocharoen, C, Suwannaroj, S, Nanagara, R. Features and outcomes of hospitalized Thai patients with pyogenic arthritis: analysis from the nationwide hospital database. Int J Rheum Dis. 2013;16 (4):387-91. doi: 10.1111/1756-185X.12071. PubMed PMID:23992256 .
  46. Foocharoen, C, Thavornpitak, Y, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. Int J Rheum Dis. 2013;16 (1):41-6. doi: 10.1111/1756-185X.12031. PubMed PMID:23441771 .
  47. Netwijitpan, S, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. Clin Rheumatol. 2013;32 (3):361-7. doi: 10.1007/s10067-012-2131-0. PubMed PMID:23224269 .
  48. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients. Int J Rheum Dis. 2012;15 (5):e90-5. doi: 10.1111/j.1756-185X.2012.01760.x. PubMed PMID:23083053 .
  49. Kunyakham, W, Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. Asian Pac J Allergy Immunol. 2012;30 (2):152-7. . PubMed PMID:22830295 .
  50. Foocharoen, C, Siriphannon, Y, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Incidence rate and causes of infection in Thai systemic sclerosis patients. Int J Rheum Dis. 2012;15 (3):277-83. doi: 10.1111/j.1756-185X.2012.01728.x. PubMed PMID:22709489 .
  51. Foocharoen, C, Nanagara, R, Suwannaroj, S, Mahakkanukrauh, A. Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment. Int J Rheum Dis. 2011;14 (4):353-60. doi: 10.1111/j.1756-185X.2011.01639.x. PubMed PMID:22004232 .
  52. Foocharoen, C, Nanagara, R, Kiatchoosakun, S, Suwannaroj, S, Mahakkanukrauh, A. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Int J Rheum Dis. 2011;14 (3):282-9. doi: 10.1111/j.1756-185X.2011.01625.x. PubMed PMID:21816025 .
  53. Foocharoen, C, Nanagara, R, Suwannaroj, S, Mahakkanukrauh, A. Clinical features and disease outcomes of undifferentiated arthritis in Thailand. Int J Rheum Dis. 2011;14 (3):e14-21. doi: 10.1111/j.1756-185X.2011.01606.x. PubMed PMID:21816008 .
  54. Foocharoen, C, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. Clin Rheumatol. 2011;30 (9):1235-40. doi: 10.1007/s10067-011-1744-z. PubMed PMID:21484224 .
  55. Foocharoen, C, Nanagara, R, Foocharoen, T, Mootsikapun, P, Suwannaroj, S, Mahakkanukrauh, A et al.. Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: a 10-year retrospective study. Southeast Asian J Trop Med Public Health. 2010;41 (6):1438-46. . PubMed PMID:21329321 .
  56. Foocharoen, C, Nanagara, R, Salang, L, Suwannaroj, S, Mahakkanukrauh, A. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. J Med Assoc Thai. 2009;92 (2):167-74. . PubMed PMID:19253790 .
  57. Kiatchoosakun, S, Ungkasekvinai, W, Wonvipaporn, C, Tatsanavivat, P, Foocharoen, C, Suwannaroj, S et al.. D-dimer and pulmonary arterial hypertension in systemic sclerosis. J Med Assoc Thai. 2007;90 (10):2024-9. . PubMed PMID:18041419 .
  58. Suwannaroj, S, Mootsikapun, P, Vipulakorn, K, Nanagara, R. Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus. J Clin Rheumatol. 2001;7 (2):83-5. doi: 10.1097/00124743-200104000-00006. PubMed PMID:17039101 .
  59. Mootsikapun, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Tuberculous pyomyositis. J Med Assoc Thai. 2003;86 (5):477-81. . PubMed PMID:12859107 .
  60. Mootsikapun, P, Mahakkanukrauh, A, Suwannaroj, S, Nanagara, R. Quinolones and Salmonella septic arthritis. J Med Assoc Thai. 2002;85 (9):984-9. . PubMed PMID:12450076 .
  61. McMurray, RW, Suwannaroj, S, Ndebele, K, Jenkins, JK. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology. 2001;69 (1):44-58. doi: 10.1159/000048757. PubMed PMID:11641617 .
  62. Jenkins, JK, Suwannaroj, S, Elbourne, KB, Ndebele, K, McMurray, RW. 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. Int Immunopharmacol. 2001;1 (11):1897-911. doi: 10.1016/s1567-5769(01)00114-x. PubMed PMID:11606022 .
  63. Suwannaroj, S, Lagoo, A, McMurray, RW. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. Lupus. 2001;10 (8):562-7. doi: 10.1191/096120301701549697. PubMed PMID:11530998 .
  64. Suwannaroj, S, Lagoo, A, Keisler, D, McMurray, RW. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE). Lupus. 2001;10 (4):258-65. doi: 10.1191/096120301680416940. PubMed PMID:11341102 .
  65. Nanagara, R, Vipulakorn, K, Suwannaroj, S, Schumacher, HR Jr. Atypical morphological characteristics and surface antigen expression of Burkholderia pseudomallei in naturally infected human synovial tissues. Mod Rheumatol. 2000;10 (3):129-36. doi: 10.3109/s101650070019. PubMed PMID:24383589 .
  66. Suwannaroj, S, Elkins, SL, McMurray, RW. Systemic lupus erythematosus and Castleman's disease. J Rheumatol. 1999;26 (6):1400-3. . PubMed PMID:10381064 .
Search PubMed